Issue Navigation
-
Review
-
230-237
Topoisomerase IIα, rather than IIβ, is a promising target in development of anti-cancer drugs.
Chen W, Qiu J, Shen YM
Drug Discov Ther. 2012; 6(5):230-237.
DOI: 10.5582/ddt.2012.v6.5.230
-
238-241
A new boronic acid-based fluorescent sensor for L-dihydroxyphenylalanine.
Wu ZY, Yang XY, Xu WF, Wang BH, Fang H
Drug Discov Ther. 2012; 6(5):238-241.
DOI: 10.5582/ddt.2012.v6.5.238
-
242-248
Sun Y, Zhao Y, Wang L, Lou HX, Cheng AX
Drug Discov Ther. 2012; 6(5):242-248.
DOI: 10.5582/ddt.2012.v6.5.242
-
249-255
Okonogi S, Chaiyana W
Drug Discov Ther. 2012; 6(5):249-255.
DOI: 10.5582/ddt.2012.v6.5.249
-
256-262
Subcutaneous concentrations following topical iontophoretic delivery of diclofenac.
Kasha PC, Anderson CR, Morris RL, Sembrowich WL, Chaturvedula A, Banga AK
Drug Discov Ther. 2012; 6(5):256-262.
DOI: 10.5582/ddt.2012.v6.5.256
-
263-268
Yamazaki N, Iizuka R, Miyazawa S, Wada Y, Shimokawa K, Ishii F
Drug Discov Ther. 2012; 6(5):263-268.
DOI: 10.5582/ddt.2012.v6.5.263
-
269-277
Development of an osmotic pump system for controlled delivery of diclofenac sodium.
Emara LH, Taha NF, Badr RM, Mursi NM
Drug Discov Ther. 2012; 6(5):269-277.
DOI: 10.5582/ddt.2012.v6.5.269
-
278-282
Yamashita S, Dohi T, Shimizu Y, Momomura S
Drug Discov Ther. 2012; 6(5):278-282.
DOI: 10.5582/ddt.2012.v6.5.278
-
283-284
A comment on: Research progress in the radioprotective effect of superoxide dismutase
Bhandari PR
Drug Discov Ther. 2012; 6(5):283-284.
DOI: 10.5582/ddt.2012.v6.5.283